Article Information
History
- April 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Emma Jones1,†,
- Holger Hummerich1,†,
- Emmanuelle Viré1,†,
- James Uphill1,
- Athanasios Dimitriadis1,
- Helen Speedy1,
- Tracy Campbell1,
- Penny Norsworthy1,
- Liam Quinn1,
- Jerome Whitfield1,
- Jacqueline Linehan1,
- Zane Jaunmuktane2,
- Sebastian Brandner3,
- Parmjit Jat1,
- Akin Nihat1,
- Tze How Mok1,
- Parvin Ahmed1,
- Steven Collins4,
- Christiane Stehmann4,
- Shannon Sarros4,
- Gabor Kovacs5,
- Michael Geschwind6,
- Aili Golubjatnikov6,
- Karl Fronztek7,
- Herbert Budka7,
- Adriano Aguzzi7,
- Hata Karamujić-Čomić8,
- Sven van der Lee8,
- Carla A Ibrahim-Verbaas8,
- Cornelia Van Duijn8,9,
- Beata Sikorska10,
- Ewa Golanska10,
- Pawel Liberski10,
- Miguel Calero11,
- Olga Calero11,
- Pascual Sanchez Juan12,
- Antonio Salas13,
- Federico Martinón-Torres14,
- Elodie Bouaziz-Amar15,
- Stephane Haik16,17,
- Jean-Louis Laplanche17,
- Jean-Phillipe Brandel16,17,
- Phillipe Amouyel18,
- Jean-Charles Lambert18,
- Piero Parchi19,21,
- Anna Bartoletti-Stella20,
- Sabina Capellari20,21,
- Anna Poleggi22,
- Anna Ladogana22,
- Maurizio Pocchiari22,
- Serena Aneli23,
- Giuseppe Matullo23,
- Richard Knight24,
- Saima Zafar25,
- Inga Zerr25,
- Stephanie Booth26,
- Michael B Coulthart27,
- Gerard H Jansen28,
- Katie Glisic29,
- Janis Blevins29,
- Pierluigi Gambetti29,
- Jiri Safar29,
- Brian Appleby29,
- John Collinge1 and
- Simon Mead1,*
- 1MRC Prion Unit at UCL, Institute of Prion Diseases, 33 Cleveland St, London, W1W 7FF; National Prion Clinic, University College London Hospitals NHS Foundation Trust, London
- 2Division of Neuropathology, University College London Hospitals NHS Foundation Trust, and Department of Clinical and Movement Neurosciences and Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, UK
- 3Division of Neuropathology, University College London Hospitals NHS Foundation Trust, and Department of Neurodegenerative disease, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG
- 4Australian National Creutzfeldt-Jakob Disease Registry, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Victoria, 3010, Australia
- 5Institute of Neurology, Medical University of Vienna, Vienna, Austria; Department of Laboratory Medicine and Pathobiology and Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, and Laboratory Medicine Program & Krembil Brain Institute, University Health Network, Toronto, Ontario Canada
- 6UCSF Memory and Aging Center, Department of Neurology, University of California, San Francisco
- 7Institute of Neuropathology, University of Zurich, Zurich, Switzerland
- 8Department of Epidemiology, Erasmus Medical Centre, Rotterdam, the Netherlands
- 9Nuffield Department of Population Health, University of Oxford, UK
- 10Laboratory of Electron Microscopy and Neuropathology, Department of Molecular Pathology and Neuropathology, Medical University of Lodz, Lodz, Poland
- 11Chronic Disease Programme (UFIEC-CROSADIS) and Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain and Alzheimer Disease Research Unit, CIEN Foundation, Queen Sofia Foundation Alzheimer Center, Chronic Disease Programme Carlos III Institute of Health and Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain
- 12Neurology Service, University Hospital Marqués de Valdecilla (University of Cantabria, CIBERNED and IDIVAL), Santander, Spain
- 13Unidade de Xenética, Instituto de Ciencias Forenses (INCIFOR), Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, Instituto de Investigaciones Sanitarias (IDIS), Hospital Clínico Universitario de Santiago (SERGAS), Galicia, Spain
- 14Translational Pediatrics and Infectious Diseases, Department of Pediatrics, Hospital Clínico Universitario de Santiago de Compostela, Galicia, Spain
- 15Department of Biochemistry and Molecular Biology, Lariboisière Hospital, AP-HP, University of Paris, France
- 16Sorbonne Université, INSERM, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France
- 17Cellule nationale de référence des maladies de Creutzfeldt-Jakob, APHP, University Hospital Pitié-Salpêtrière, Paris, France
- 18Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE, Labex DISTALZ, Lille, France
- 19IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy
- 20Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy
- 21Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
- 22Department of Neuroscience, Istituto Superiore di Sanità, Rome, Italy
- 23Department of Medical Sciences, Università degli studi di Torino, Via Verdi, Torino, Italy
- 24National CJD Research and Surveillance Unit, Edinburgh, UK
- 25Department of Neurology, Clinical Dementia Center and National Reference Center for CJD Surveillance, University Medical School; German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany
- 26Prion Disease Program, Public Health Agency of Canada, Winnipeg, Canada
- 27Canadian Creutzfeldt-Jakob Disease Surveillance System, Public Health Agency of Canada, Ottawa, Canada
- 28Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada
- 29Departments of Pathology and Neurology, Case Western Reserve University, Cleveland, OH, USA; National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH, USA
- ↵*Corresponding author; email: s.mead{at}prion.ucl.ac.uk
↵† Equal contribution
Posted April 11, 2020.
Genome-wide association study identifies risk variants for sporadic Creutzfeldt-Jakob disease in STX6 and GAL3ST1
